medical device investing ChroMedX Strengthens Board of Directors with the Appointment of Dr. Richard Janeczko
Genetic Technologies and the University of Melbourne Sign License Agreement to Develop Colorectal Cancer Test
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
